Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
01/2005
01/26/2005EP1499612A1 Piperidine ouracil used as a medicament for treating bacterial infections
01/26/2005EP1499609A2 Pesticidal heterocycles
01/26/2005EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
01/26/2005EP1499594A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
01/26/2005EP1499316A1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists
01/26/2005EP1499314A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
01/26/2005EP1499311A1 Substituted benzazoles and use thereof as raf kinase inhibitors
01/26/2005EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
01/26/2005EP1379522B1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
01/26/2005EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
01/26/2005CN1571667A Inhibitors of dipeptidyl peptidase ó¶
01/26/2005CN1569834A Benzyloxy substituted indole compound and its analog and their production method and application
01/26/2005CN1186343C Method of preparing vitamin B1 hydrochloride using thiohydrothiamine
01/26/2005CN1186342C Substituted (4-bromopyrazole-3-yl) indole
01/26/2005CN1186328C Substd. 5-benzyl-2, 4-diaminopyrimidines
01/26/2005CN1186326C Propane-1, 3-dione derivatives
01/26/2005CN1186322C Proline derivatives and use thereof as drugs
01/26/2005CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them
01/25/2005US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
01/25/2005US6846928 Compositions useful as inhibitors of protein kinases
01/25/2005US6846839 Identifying indolinone compounds that inhibit growth factor stimulated cell proliferation by contacting cells with compounds and with selected growth factors and monitoring inhibitory effect
01/25/2005US6846834 Antiinflammation agents
01/25/2005US6846829 N-heterocyclic derivatives as NOS inhibitors
01/25/2005US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents
01/25/2005US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents
01/25/2005US6846825 Antibacterial agents
01/25/2005US6846820 For therapy of diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals
01/25/2005CA2309352C Heterocyclic-substituted tricyclics as thrombin receptor antagonists
01/25/2005CA2170637C Pyridazinone derivatives or their salts, processes for their production, and anti-shock agents containing them
01/25/2005CA2103383C Quinazoline derivatives
01/20/2005WO2005006807A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone
01/20/2005WO2005006806A1 Wireless microphone communication system
01/20/2005WO2005005428A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
01/20/2005WO2005005424A1 Aztreonam l-lysine and methods for the preparation thereof
01/20/2005WO2005005423A1 Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators
01/20/2005WO2005005398A2 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
01/20/2005WO2005005397A1 5-substituted quinazolinone derivatives
01/20/2005WO2005005395A2 Arylamine-substituted quinazolinone compounds
01/20/2005WO2005005392A1 Azacyclic compounds as inhibitors of sensory neurone specific channels
01/20/2005WO2005004866A1 Therapeutic agents useful for treating pain
01/20/2005WO2005004606A2 Pyridinylanilides
01/20/2005WO2004111046A3 Thiazoles as inhibitors of the alk- 5 receptor
01/20/2005WO2004100865A3 New benzimidazole derivatives
01/20/2005WO2004096129A3 Inhibitors of akt activity
01/20/2005WO2004092166A3 Cgrp receptor antagonists
01/20/2005WO2004074218A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
01/20/2005WO2004069793A3 Novel 2-substituted cyclic amines as calcium sensing receptor modulators
01/20/2005US20050014942 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation
01/20/2005US20050014939 E.g., N-[4-(2-Pyrrolidinylethoxy)phenyl]-4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxamide; treating diseases associated with pathogenic agonism, inverse agonism or antagonism of the GABAA receptor such as anxiety, depression, a sleep disorder, or cognitive impairment
01/20/2005US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase
01/20/2005US20050014833 Cyclic compound and ppar agonist
01/20/2005US20050014813 High yield; synthetic pharmaceutical intermediate; diabetes, insulin sensitizers
01/20/2005US20050014812 Benzimidazole compounds
01/20/2005US20050014806 Substituted isoxazoles and their use as antibiotics
01/20/2005US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents
01/20/2005US20050014803 Enzyme inhibitors
01/20/2005US20050014798 Blending mixture of rosiglitazone and maleic acid; salt formation; crystal structure; antidiabetic agents
01/20/2005US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
01/20/2005US20050014786 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
01/20/2005US20050014769 Anticancer agents; controlling apoptosis
01/20/2005US20050014767 Controlling cell proliferative
01/20/2005US20050014765 Aryl-heteroaromatic products, compositions comprising them and use
01/20/2005US20050014757 Serotonin receptor antagonist; psychological disorders; side effect reduction
01/20/2005US20050014750 Isochroman compounds for treatment of cns disorders
01/20/2005US20050014748 N-type calcium channel blockers
01/20/2005US20050014745 Such as 3-[[4-(4-chlorophenyl)-2-thiazolyl]methoxy]-N-propyl-benzenemethanamine; nicotinamide adenine dinucleotide oxidase hydride donor inhibitors
01/20/2005US20050014739 Aztreonam beta polymorph with very low residual solvent content
01/20/2005US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
01/20/2005US20050014700 Cbi analogues of cc-1065 and the duocarmycins
01/20/2005DE102004014061A1 Amid-substituierte 1,2,4-Triazin-5(2H)-one Amide substituted 1,2,4-triazine-5 (2H) -ones
01/20/2005CA2530450A1 5-substituted quinazolinone derivatives
01/20/2005CA2530312A1 Arylamine-substituted quinazolinone compounds
01/19/2005EP1498419A1 Process for preparing alkali metal salts of hydrophobic sulfonamides
01/19/2005EP1498418A1 Sulfonamides for treatment of endothelin-mediated disorders
01/19/2005EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
01/19/2005EP1498109A1 Furan derivatives and dyeing composition comprising a furan derivative as coupler
01/19/2005EP1497672A2 Ultrasonic doppler effect speed measurement
01/19/2005EP1497287A1 Quinolinone derivatives
01/19/2005EP1497286A1 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
01/19/2005EP1497285A1 Benzoxazinone-derived compounds, their preparation und use as medicaments
01/19/2005EP1497284A2 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors
01/19/2005EP1497282A2 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4 protease
01/19/2005EP1497279A2 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands
01/19/2005EP1497278A1 Heterocyclic amide derivatives as cytokine inhibitors
01/19/2005EP1497271A1 Indane acetic acid derivatives and their use as pharmaceutical agents
01/19/2005EP1496906A1 Inhibitors of akt activity
01/19/2005EP1496896A1 Inhibitors of akt activity
01/19/2005EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators
01/19/2005EP1395574B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
01/19/2005EP1287018B1 Thrombin inhibitors
01/19/2005CN1568323A Activator for peroxisome proliferator-activated receptor delta
01/19/2005CN1568321A Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists
01/19/2005CN1568310A Heterocyclic inhibitors of glycogen synthase kinase GSK-3
01/19/2005CN1568190A Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators
01/19/2005CN1568188A Nociceptin analogs
01/19/2005CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof
01/19/2005CN1568186A Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage
01/19/2005CN1568185A Compounds effecting glucokinase
01/19/2005CN1568144A Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
01/19/2005CN1566112A Diastereomeric selective preparation method of lamivudine